DISSEMINATED BLASTOMYCOSIS

DISSEMINATED BLASTOMYCOSIS was reported 171 times

DISSEMINATED BLASTOMYCOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Selective T Cell Costimulation Blocker [EPC] 9 0.0019
1 Lipid-based Polyene Antifungal [EPC] 18 0.0014
2 CD52-directed Cytolytic Antibody [EPC] 10 0.0005
3 Polyene Antifungal [EPC] 18 0.0004
4 Carbonic Anhydrase Inhibitor [EPC] 7 0.0003
5 Echinocandin Antifungal [EPC] 2 0.0002
6 Interleukin-1 Receptor Antagonist [EPC] 3 0.0002
7 Calcineurin Inhibitor Immunosuppressant [EPC] 18 0.0001
8 Corticosteroid [EPC] 149 0.0001
9 Azole Antifungal [EPC] 17 0.0001
10 Lipopeptide Antibacterial [EPC] 1 0.0001
11 Antimetabolite Immunosuppressant [EPC] 2 0.0001
12 Sulfone [EPC] 1 0.0001
13 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0001
14 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
15 CD20-directed Cytolytic Antibody [EPC] 21 0.0001
16 Rifamycin Antibacterial [EPC] 2 0.0001
17 Alkylating Drug [EPC] 13 0.0001
18 Alkaloid [EPC] 1 0.0000
19 Janus Kinase Inhibitor [EPC] 6 0.0000
20 Interleukin-6 Receptor Antagonist [EPC] 5 0.0000
21 Glycopeptide Antibacterial [EPC] 2 0.0000
22 Purine Antimetabolite [EPC] 2 0.0000
23 Kinase Inhibitor [EPC] 8 0.0000
24 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
25 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
26 Tumor Necrosis Factor Blocker [EPC] 9 0.0000
27 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
28 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
29 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000